42 related articles for article (PubMed ID: 37519108)
1. [The study of clinical characteristics and prognosis of RUNX1-RUNX1T1 positive acute myeloid leukemia based on next-generation sequencing].
Wang YL; Gao SJ; Su L; Liu YJ; Zhang YW; Du YZ
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):851-854. PubMed ID: 38049338
[No Abstract] [Full Text] [Related]
2. [The prognostic value of cloned genetic mutations detected by second-generation sequencing in RUNX1-RUNX1T1 positive acute myeloid leukemia patients receiving intensive consolidation therapy].
Yu JQ; Xue SL; Li Z; Wang J; Wang C; Chu XL; Han R; Tao T; Qiu QC; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):210-215. PubMed ID: 32311890
[No Abstract] [Full Text] [Related]
3. Not only mutations but also tumorigenesis can be substantially attributed to DNA damage from reactive oxygen species in RUNX1::RUNX1T1-fusion-positive acute myeloid leukemia.
Mandell JD; Fisk JN; Cyrenne E; Xu ML; Cannataro VL; Townsend JP
Leukemia; 2022 Dec; 36(12):2931-2933. PubMed ID: 36369483
[No Abstract] [Full Text] [Related]
4. Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with RUNX1::RUNX1T1.
Li XP; Dai Y; Zhang WN; Pan MM; Mao J; Zhao B; Jiang L; Gao Y
Int Immunopharmacol; 2023 Dec; 125(Pt B):111178. PubMed ID: 37951201
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia.
Sun Y; Wang X; Chen WM; Hao Y; Li LD; Li JY; Sun K; Shi ZY; Jiang H; Jiang Q; Huang XJ; Qin YZ
Hematol Oncol; 2024 Mar; 42(2):e3264. PubMed ID: 38461410
[TBL] [Abstract][Full Text] [Related]
6. Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study.
Wang M; Cao HY; Tan KW; Qiu QC; Huang YH; Ge SS; Wang ZH; Chen J; Tang XW; Wu DP; Xue SL; Li Z; Dai HP
Blood Cancer J; 2023 Nov; 13(1):173. PubMed ID: 38012154
[No Abstract] [Full Text] [Related]
7. Acute myeloid leukaemia (AML) with KMT2A rearrangement presented with haemophagocytic lymphohistiocytosis (HLH).
Xu K; Nacheva E
Int J Lab Hematol; 2024 Apr; 46(2):214-215. PubMed ID: 37807295
[No Abstract] [Full Text] [Related]
8. [An interlaboratory comparison study on the detection of RUNX1-RUNX1T1 fusion transcript levels and WT1 transcript levels].
Qin YZ; Zhu LW; Lin S; Geng SX; Liu SW; Cheng H; Wu CY; Xiao M; Li XQ; Hu RP; Wang LL; Liu HY; Ma DX; Guan T; Ye YX; Niu T; Cen JN; Lu LS; Sun L; Yang TH; Wang YG; Li T; Wang Y; Li QH; Zhao XS; Li LD; Chen WM; Long LY; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):889-894. PubMed ID: 31856435
[No Abstract] [Full Text] [Related]
9. RUNX1 and inv(16) are frenemies in AML.
Rao S
Blood; 2020 Nov; 136(21):2361-2362. PubMed ID: 33211836
[TBL] [Abstract][Full Text] [Related]
10. Extensive Hemophagocytic Lymphohistiocytosis Associated With Aggressive Natural Killer Cell Leukemia.
Zhang X; Shi M
Mayo Clin Proc; 2023 Sep; 98(9):1345-1346. PubMed ID: 37661142
[No Abstract] [Full Text] [Related]
11. Hemophagocytosis by multinucleated leukemic blasts, basophilia, and micromegakaryocytes in AML with TLS::ERG.
Huang X; Li T; Zhang Y; Gao X; Long F
Ann Hematol; 2023 Nov; 102(11):3279-3281. PubMed ID: 37530852
[No Abstract] [Full Text] [Related]
12. Case report: Positive response to venetoclax and azacitidine in the treatment of acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype.
Wen X; Yu J; Fan J; Zhu S; Zheng H
Pediatr Blood Cancer; 2023 Nov; 70(11):e30597. PubMed ID: 37523330
[No Abstract] [Full Text] [Related]
13. Insulin-like growth factor 1 receptor inhibits the proliferation of acute myeloid leukaemia cells via NK cell activation.
Wang S; Wang X; Shen K; Wei C; Li J
Ann Hematol; 2023 Sep; 102(9):2353-2364. PubMed ID: 37522970
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic Lymphohistiocytosis in
Huang X; Long F; Zhang Y; Gao X; Li T
Turk J Haematol; 2023 Aug; 40(3):210-212. PubMed ID: 37519108
[No Abstract] [Full Text] [Related]
15. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.
Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G
Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884
[TBL] [Abstract][Full Text] [Related]
16. The First Case of Acute Myeloid Leukemia With a Novel Five-way Variant Translocation of
Jo YH; Han EA; Park SK; Jeon BR; Jang MA
Ann Lab Med; 2023 May; 43(3):315-318. PubMed ID: 36544347
[No Abstract] [Full Text] [Related]
17. Relapsed RUNX1-RUNX1T1-positive acute myeloid leukemia with pseudo-Chediak-Higashi granules.
Kondo H; Kanayama T; Matsumura U; Urata T; Osone S; Imamura T; Inaba T; Hosoi H
Int J Hematol; 2021 May; 113(5):616-617. PubMed ID: 33782817
[No Abstract] [Full Text] [Related]
18. The RUNX1/RUNX1T1 network: translating insights into therapeutic options.
Swart LE; Heidenreich O
Exp Hematol; 2021 Feb; 94():1-10. PubMed ID: 33217477
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
